QQQ   419.00 (+1.05%)
AAPL   166.45 (+0.88%)
MSFT   401.26 (+0.54%)
META   483.33 (+0.47%)
GOOGL   156.73 (+1.71%)
AMZN   177.11 (+1.42%)
TSLA   142.03 (-3.41%)
NVDA   793.40 (+4.12%)
AMD   148.44 (+1.23%)
NIO   4.01 (+5.53%)
BABA   70.78 (+2.48%)
T   16.31 (-1.21%)
F   12.84 (+5.77%)
MU   108.74 (+1.85%)
GE   150.16 (+1.42%)
CGC   7.86 (-0.88%)
DIS   112.11 (-0.44%)
AMC   3.43 (+8.54%)
PFE   26.33 (+1.27%)
PYPL   63.36 (+1.69%)
XOM   120.60 (+0.60%)
QQQ   419.00 (+1.05%)
AAPL   166.45 (+0.88%)
MSFT   401.26 (+0.54%)
META   483.33 (+0.47%)
GOOGL   156.73 (+1.71%)
AMZN   177.11 (+1.42%)
TSLA   142.03 (-3.41%)
NVDA   793.40 (+4.12%)
AMD   148.44 (+1.23%)
NIO   4.01 (+5.53%)
BABA   70.78 (+2.48%)
T   16.31 (-1.21%)
F   12.84 (+5.77%)
MU   108.74 (+1.85%)
GE   150.16 (+1.42%)
CGC   7.86 (-0.88%)
DIS   112.11 (-0.44%)
AMC   3.43 (+8.54%)
PFE   26.33 (+1.27%)
PYPL   63.36 (+1.69%)
XOM   120.60 (+0.60%)
QQQ   419.00 (+1.05%)
AAPL   166.45 (+0.88%)
MSFT   401.26 (+0.54%)
META   483.33 (+0.47%)
GOOGL   156.73 (+1.71%)
AMZN   177.11 (+1.42%)
TSLA   142.03 (-3.41%)
NVDA   793.40 (+4.12%)
AMD   148.44 (+1.23%)
NIO   4.01 (+5.53%)
BABA   70.78 (+2.48%)
T   16.31 (-1.21%)
F   12.84 (+5.77%)
MU   108.74 (+1.85%)
GE   150.16 (+1.42%)
CGC   7.86 (-0.88%)
DIS   112.11 (-0.44%)
AMC   3.43 (+8.54%)
PFE   26.33 (+1.27%)
PYPL   63.36 (+1.69%)
XOM   120.60 (+0.60%)
QQQ   419.00 (+1.05%)
AAPL   166.45 (+0.88%)
MSFT   401.26 (+0.54%)
META   483.33 (+0.47%)
GOOGL   156.73 (+1.71%)
AMZN   177.11 (+1.42%)
TSLA   142.03 (-3.41%)
NVDA   793.40 (+4.12%)
AMD   148.44 (+1.23%)
NIO   4.01 (+5.53%)
BABA   70.78 (+2.48%)
T   16.31 (-1.21%)
F   12.84 (+5.77%)
MU   108.74 (+1.85%)
GE   150.16 (+1.42%)
CGC   7.86 (-0.88%)
DIS   112.11 (-0.44%)
AMC   3.43 (+8.54%)
PFE   26.33 (+1.27%)
PYPL   63.36 (+1.69%)
XOM   120.60 (+0.60%)

Halozyme Therapeutics (HALO) News Today

$38.66
+0.02 (+0.05%)
(As of 03:58 PM ET)
SourceHeadline
marketbeat.com logoLouisiana State Employees Retirement System Purchases New Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - April 22 at 5:12 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Holdings Raised by Kornitzer Capital Management Inc. KS
marketbeat.com - April 21 at 7:54 AM
MarketBeat logoHC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)
americanbankingnews.com - April 20 at 7:04 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Knights of Columbus Asset Advisors LLC
marketbeat.com - April 19 at 1:38 PM
insidertrades.com logoMichael J. Labarre Sells 10,000 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stock
insidertrades.com - April 19 at 4:50 AM
investing.com logoHalozyme Therapeutics CTO sells $768,390 in stock
investing.com - April 19 at 12:30 AM
insidertrades.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Michael J. Labarre Sells 10,000 Shares
insidertrades.com - April 18 at 6:32 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells $384,900.00 in Stock
marketbeat.com - April 17 at 9:22 PM
markets.businessinsider.com logoBuy Rating Affirmed for Halozyme on OCREVUS SC Prospects and Enhanze Technology Potential
markets.businessinsider.com - April 17 at 6:09 PM
marketbeat.com logoHalozyme Therapeutics' (HALO) Buy Rating Reiterated at HC Wainwright
marketbeat.com - April 17 at 4:27 PM
MarketBeat logoHalozyme Therapeutics' (HALO) "Buy" Rating Reaffirmed at Benchmark
americanbankingnews.com - April 17 at 4:46 AM
markets.businessinsider.com logo9 Analysts Have This To Say About Halozyme Therapeutics
markets.businessinsider.com - April 16 at 1:02 PM
marketbeat.com logoAllspring Global Investments Holdings LLC Lowers Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - April 14 at 5:36 AM
MarketBeat logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Brokerages
americanbankingnews.com - April 13 at 2:28 AM
marketbeat.com logoHarvey Capital Management Inc. Invests $5.92 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - April 12 at 5:41 PM
seekingalpha.com logoHalozyme's Strategic Partnerships Fueling Next-Gen Therapeutics
seekingalpha.com - April 10 at 6:50 AM
nasdaq.com logoValidea Detailed Fundamental Analysis - HALO
nasdaq.com - April 10 at 12:59 AM
stocknews.com logo3 Biotech Stocks to Buy in 2024
stocknews.com - April 9 at 6:02 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Halozyme (HALO) and MacroGenics (MGNX)
markets.businessinsider.com - April 8 at 1:12 PM
marketbeat.com logoResearch Analysts Offer Predictions for Halozyme Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:HALO)
marketbeat.com - April 5 at 8:06 AM
finance.yahoo.com logoIs Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?
finance.yahoo.com - April 4 at 9:44 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Position Lowered by Redwood Investments LLC
marketbeat.com - April 1 at 6:48 AM
finance.yahoo.com logoMirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 29 at 3:11 PM
investorplace.com logoThe 3 Best Biotech Stocks to Buy in Q2 2024
investorplace.com - March 29 at 6:40 AM
finance.yahoo.com logoFate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 27 at 3:29 PM
marketbeat.com logoWellington Management Group LLP Has $5.95 Million Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - March 26 at 4:17 AM
marketbeat.com logoVanguard Group Inc. Sells 29,621 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - March 24 at 4:30 AM
marketbeat.com logoZacks Research Analysts Raise Earnings Estimates for Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - March 20 at 6:54 AM
marketbeat.com logoQ2 2025 Earnings Forecast for Halozyme Therapeutics, Inc. Issued By Zacks Research (NASDAQ:HALO)
marketbeat.com - March 19 at 7:14 AM
finance.yahoo.com logoHALO Apr 2024 35.000 put
finance.yahoo.com - March 16 at 7:36 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Expected to Earn Q1 2024 Earnings of $0.71 Per Share
marketbeat.com - March 15 at 7:20 AM
marketbeat.com logoInsider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells 10,000 Shares of Stock
marketbeat.com - March 13 at 7:34 PM
investorplace.com logo7 Biotech Stocks to Buy as Sector Rotation Ramps Up
investorplace.com - March 13 at 2:25 PM
finance.yahoo.com logoI:RUT Mar 2024 Weekly 1905.000
finance.yahoo.com - March 12 at 9:17 AM
marketbeat.com logoAurora Investment Counsel Buys Shares of 35,261 Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - March 11 at 1:31 PM
markets.businessinsider.com logoTD Cowen Reaffirms Their Buy Rating on Halozyme (HALO)
markets.businessinsider.com - March 8 at 4:16 PM
marketbeat.com logoAdage Capital Partners GP L.L.C. Acquires Shares of 400,000 Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - March 8 at 7:27 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Kennedy Capital Management LLC
marketbeat.com - March 5 at 3:41 PM
marketbeat.com logoEnvestnet Asset Management Inc. Raises Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - March 4 at 5:01 AM
msn.com logoTD Cowen Initiates Coverage of Halozyme Therapeutics (HALO) with Outperform Recommendation
msn.com - March 1 at 9:14 AM
marketbeat.com logoHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Mariner LLC
marketbeat.com - March 1 at 5:32 AM
stocknews.com logo3 Biotech Stocks for Sustainable Returns
stocknews.com - February 29 at 5:01 PM
finance.yahoo.com logoInsider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...
finance.yahoo.com - February 29 at 9:44 AM
marketbeat.com logoTrexquant Investment LP Buys 13,258 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - February 29 at 7:46 AM
marketbeat.com logoClough Capital Partners L P Reduces Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - February 28 at 9:54 AM
prnewswire.com logoHalozyme to Participate in Upcoming Investor Conferences
prnewswire.com - February 27 at 8:30 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Has $6.61 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - February 26 at 8:18 AM
finance.yahoo.com logoAnalyst Estimates: Here's What Brokers Think Of Halozyme Therapeutics, Inc. (NASDAQ:HALO) After Its Full-Year Report
finance.yahoo.com - February 23 at 7:45 AM
marketbeat.com logoFuller & Thaler Asset Management Inc. Grows Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
marketbeat.com - February 22 at 9:25 AM
finance.yahoo.com logoHalozyme Therapeutics Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - February 22 at 8:03 AM
Get Halozyme Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter.

Incredible Opportunity to Retire FAST! (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

HALO Media Mentions By Week

HALO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HALO
News Sentiment

0.71

0.48

Average
Medical
News Sentiment

HALO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HALO Articles
This Week

15

5

HALO Articles
Average Week

Get Halozyme Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HALO) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners